Head to head

Peptide comparisons.

Every same-category pair, put side by side on regulatory status, mechanism and published evidence. No winner is declared for money; where the honest answer is “we don't know yet,” we say so.

304 comparisons · 8 categories

Metabolic & GLP-1.

TirzepatidevsSemaglutide

The two GLP-1 heavyweights: one a dual GIP/GLP-1 agonist, the other GLP-1-only.

RetatrutidevsTirzepatide

Triple agonist still in trials vs the approved dual agonist.

SemaglutidevsLiraglutide

Once-weekly vs once-daily GLP-1: same class, different half-life.

CagriSemavsTirzepatide

Amylin+GLP-1 combo vs GIP+GLP-1: two routes to the same goal.

AdipotidevsAOD-9604

Two research / preclinical compounds in metabolic & glp-1, compared on the published evidence.

CagrilintidevsAdipotide

In human trials vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

CagriSemavsAdipotide

In human trials vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

AdipotidevsHGH Fragment 176-191

Two research / preclinical compounds in metabolic & glp-1, compared on the published evidence.

LiraglutidevsAdipotide

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

MazdutidevsAdipotide

In human trials vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

RetatrutidevsAdipotide

In human trials vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

SemaglutidevsAdipotide

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

SurvodutidevsAdipotide

In human trials vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

TirzepatidevsAdipotide

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

CagrilintidevsAOD-9604

In human trials vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

CagriSemavsAOD-9604

In human trials vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

AOD-9604vsHGH Fragment 176-191

Two research / preclinical compounds in metabolic & glp-1, compared on the published evidence.

LiraglutidevsAOD-9604

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

MazdutidevsAOD-9604

In human trials vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

RetatrutidevsAOD-9604

In human trials vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

SemaglutidevsAOD-9604

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

SurvodutidevsAOD-9604

In human trials vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

TirzepatidevsAOD-9604

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

CagrilintidevsCagriSema

Two in human trials compounds in metabolic & glp-1, compared on the published evidence.

CagrilintidevsHGH Fragment 176-191

In human trials vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

LiraglutidevsCagrilintide

FDA-approved vs In human trials, a regulatory-reality comparison inside metabolic & glp-1.

CagrilintidevsMazdutide

Two in human trials compounds in metabolic & glp-1, compared on the published evidence.

CagrilintidevsRetatrutide

Two in human trials compounds in metabolic & glp-1, compared on the published evidence.

SemaglutidevsCagrilintide

FDA-approved vs In human trials, a regulatory-reality comparison inside metabolic & glp-1.

CagrilintidevsSurvodutide

Two in human trials compounds in metabolic & glp-1, compared on the published evidence.

TirzepatidevsCagrilintide

FDA-approved vs In human trials, a regulatory-reality comparison inside metabolic & glp-1.

CagriSemavsHGH Fragment 176-191

In human trials vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

LiraglutidevsCagriSema

FDA-approved vs In human trials, a regulatory-reality comparison inside metabolic & glp-1.

CagriSemavsMazdutide

Two in human trials compounds in metabolic & glp-1, compared on the published evidence.

CagriSemavsRetatrutide

Two in human trials compounds in metabolic & glp-1, compared on the published evidence.

SemaglutidevsCagriSema

FDA-approved vs In human trials, a regulatory-reality comparison inside metabolic & glp-1.

CagriSemavsSurvodutide

Two in human trials compounds in metabolic & glp-1, compared on the published evidence.

LiraglutidevsHGH Fragment 176-191

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

MazdutidevsHGH Fragment 176-191

In human trials vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

RetatrutidevsHGH Fragment 176-191

In human trials vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

SemaglutidevsHGH Fragment 176-191

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

SurvodutidevsHGH Fragment 176-191

In human trials vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

TirzepatidevsHGH Fragment 176-191

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside metabolic & glp-1.

LiraglutidevsMazdutide

FDA-approved vs In human trials, a regulatory-reality comparison inside metabolic & glp-1.

LiraglutidevsRetatrutide

FDA-approved vs In human trials, a regulatory-reality comparison inside metabolic & glp-1.

LiraglutidevsSurvodutide

FDA-approved vs In human trials, a regulatory-reality comparison inside metabolic & glp-1.

LiraglutidevsTirzepatide

Two fda-approved compounds in metabolic & glp-1, compared on the published evidence.

MazdutidevsRetatrutide

Two in human trials compounds in metabolic & glp-1, compared on the published evidence.

SemaglutidevsMazdutide

FDA-approved vs In human trials, a regulatory-reality comparison inside metabolic & glp-1.

MazdutidevsSurvodutide

Two in human trials compounds in metabolic & glp-1, compared on the published evidence.

TirzepatidevsMazdutide

FDA-approved vs In human trials, a regulatory-reality comparison inside metabolic & glp-1.

SemaglutidevsRetatrutide

FDA-approved vs In human trials, a regulatory-reality comparison inside metabolic & glp-1.

RetatrutidevsSurvodutide

Two in human trials compounds in metabolic & glp-1, compared on the published evidence.

SemaglutidevsSurvodutide

FDA-approved vs In human trials, a regulatory-reality comparison inside metabolic & glp-1.

TirzepatidevsSurvodutide

FDA-approved vs In human trials, a regulatory-reality comparison inside metabolic & glp-1.

Healing & recovery.

BPC-157vsTB-500

The two most-stacked 'healing' research peptides, often run together, rarely studied in humans.

TB-500vsThymosin β-4

A synthetic fragment vs the full parent peptide it's derived from.

B7-33vsBPC-157

Two research / preclinical compounds in healing & recovery, compared on the published evidence.

LarazotidevsB7-33

In human trials vs Research / preclinical, a regulatory-reality comparison inside healing & recovery.

Pentosan PolysulfatevsB7-33

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside healing & recovery.

B7-33vsTB-500

Two research / preclinical compounds in healing & recovery, compared on the published evidence.

B7-33vsThymosin β-4

Two research / preclinical compounds in healing & recovery, compared on the published evidence.

LarazotidevsBPC-157

In human trials vs Research / preclinical, a regulatory-reality comparison inside healing & recovery.

Pentosan PolysulfatevsBPC-157

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside healing & recovery.

BPC-157vsThymosin β-4

Two research / preclinical compounds in healing & recovery, compared on the published evidence.

Pentosan PolysulfatevsLarazotide

FDA-approved vs In human trials, a regulatory-reality comparison inside healing & recovery.

LarazotidevsTB-500

In human trials vs Research / preclinical, a regulatory-reality comparison inside healing & recovery.

LarazotidevsThymosin β-4

In human trials vs Research / preclinical, a regulatory-reality comparison inside healing & recovery.

Pentosan PolysulfatevsTB-500

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside healing & recovery.

Pentosan PolysulfatevsThymosin β-4

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside healing & recovery.

Growth hormone.

CJC-1295vsIpamorelin

A GHRH analog vs a ghrelin-mimetic: the classic GH-stack pairing.

IpamorelinvsSermorelin

Two of the gentlest GH secretagogues, compared on evidence and status.

CJC-1295 DACvsCJC-1295

With DAC vs without: the half-life question that changes everything.

TesamorelinvsSermorelin

An FDA-approved GHRH analog vs a research-only one.

GHRP-6vsGHRP-2

Two ghrelin-mimetic secretagogues separated mostly by side-effect profile.

ACE-031vsCJC-1295

In human trials vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

ACE-031vsCJC-1295 DAC

In human trials vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

ACE-031vsFollistatin-344

In human trials vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

ACE-031vsGHRP-1

In human trials vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

ACE-031vsGHRP-2

In human trials vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

ACE-031vsGHRP-6

In human trials vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

ACE-031vsHexarelin

In human trials vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

Human Growth HormonevsACE-031

FDA-approved vs In human trials, a regulatory-reality comparison inside growth hormone.

ACE-031vsIGF-1 LR3

In human trials vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

ACE-031vsIpamorelin

In human trials vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

ACE-031vsMGF

In human trials vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

ACE-031vsMod-GRF (1-29)

In human trials vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

ACE-031vsPEG-MGF

In human trials vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

ACE-031vsSermorelin

In human trials vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

TesamorelinvsACE-031

FDA-approved vs In human trials, a regulatory-reality comparison inside growth hormone.

CJC-1295vsFollistatin-344

Two research / preclinical compounds in growth hormone, compared on the published evidence.

CJC-1295vsGHRP-1

Two research / preclinical compounds in growth hormone, compared on the published evidence.

CJC-1295vsGHRP-2

Two research / preclinical compounds in growth hormone, compared on the published evidence.

CJC-1295vsGHRP-6

Two research / preclinical compounds in growth hormone, compared on the published evidence.

CJC-1295vsHexarelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

Human Growth HormonevsCJC-1295

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

CJC-1295vsIGF-1 LR3

Two research / preclinical compounds in growth hormone, compared on the published evidence.

CJC-1295vsMGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

CJC-1295vsMod-GRF (1-29)

Two research / preclinical compounds in growth hormone, compared on the published evidence.

CJC-1295vsPEG-MGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

CJC-1295vsSermorelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

TesamorelinvsCJC-1295

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

CJC-1295 DACvsFollistatin-344

Two research / preclinical compounds in growth hormone, compared on the published evidence.

CJC-1295 DACvsGHRP-1

Two research / preclinical compounds in growth hormone, compared on the published evidence.

CJC-1295 DACvsGHRP-2

Two research / preclinical compounds in growth hormone, compared on the published evidence.

CJC-1295 DACvsGHRP-6

Two research / preclinical compounds in growth hormone, compared on the published evidence.

CJC-1295 DACvsHexarelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

Human Growth HormonevsCJC-1295 DAC

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

CJC-1295 DACvsIGF-1 LR3

Two research / preclinical compounds in growth hormone, compared on the published evidence.

CJC-1295 DACvsIpamorelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

CJC-1295 DACvsMGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

CJC-1295 DACvsMod-GRF (1-29)

Two research / preclinical compounds in growth hormone, compared on the published evidence.

CJC-1295 DACvsPEG-MGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

CJC-1295 DACvsSermorelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

TesamorelinvsCJC-1295 DAC

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

Follistatin-344vsGHRP-1

Two research / preclinical compounds in growth hormone, compared on the published evidence.

Follistatin-344vsGHRP-2

Two research / preclinical compounds in growth hormone, compared on the published evidence.

Follistatin-344vsGHRP-6

Two research / preclinical compounds in growth hormone, compared on the published evidence.

Follistatin-344vsHexarelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

Human Growth HormonevsFollistatin-344

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

Follistatin-344vsIGF-1 LR3

Two research / preclinical compounds in growth hormone, compared on the published evidence.

Follistatin-344vsIpamorelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

Follistatin-344vsMGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

Follistatin-344vsMod-GRF (1-29)

Two research / preclinical compounds in growth hormone, compared on the published evidence.

Follistatin-344vsPEG-MGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

Follistatin-344vsSermorelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

TesamorelinvsFollistatin-344

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

GHRP-1vsGHRP-2

Two research / preclinical compounds in growth hormone, compared on the published evidence.

GHRP-1vsGHRP-6

Two research / preclinical compounds in growth hormone, compared on the published evidence.

GHRP-1vsHexarelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

Human Growth HormonevsGHRP-1

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

GHRP-1vsIGF-1 LR3

Two research / preclinical compounds in growth hormone, compared on the published evidence.

GHRP-1vsIpamorelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

GHRP-1vsMGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

GHRP-1vsMod-GRF (1-29)

Two research / preclinical compounds in growth hormone, compared on the published evidence.

GHRP-1vsPEG-MGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

GHRP-1vsSermorelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

TesamorelinvsGHRP-1

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

GHRP-2vsHexarelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

Human Growth HormonevsGHRP-2

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

GHRP-2vsIGF-1 LR3

Two research / preclinical compounds in growth hormone, compared on the published evidence.

GHRP-2vsIpamorelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

GHRP-2vsMGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

GHRP-2vsMod-GRF (1-29)

Two research / preclinical compounds in growth hormone, compared on the published evidence.

GHRP-2vsPEG-MGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

GHRP-2vsSermorelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

TesamorelinvsGHRP-2

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

GHRP-6vsHexarelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

Human Growth HormonevsGHRP-6

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

GHRP-6vsIGF-1 LR3

Two research / preclinical compounds in growth hormone, compared on the published evidence.

GHRP-6vsIpamorelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

GHRP-6vsMGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

GHRP-6vsMod-GRF (1-29)

Two research / preclinical compounds in growth hormone, compared on the published evidence.

GHRP-6vsPEG-MGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

GHRP-6vsSermorelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

TesamorelinvsGHRP-6

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

Human Growth HormonevsHexarelin

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

HexarelinvsIGF-1 LR3

Two research / preclinical compounds in growth hormone, compared on the published evidence.

HexarelinvsIpamorelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

HexarelinvsMGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

HexarelinvsMod-GRF (1-29)

Two research / preclinical compounds in growth hormone, compared on the published evidence.

HexarelinvsPEG-MGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

HexarelinvsSermorelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

TesamorelinvsHexarelin

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

Human Growth HormonevsIGF-1 LR3

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

Human Growth HormonevsIpamorelin

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

Human Growth HormonevsMGF

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

Human Growth HormonevsMod-GRF (1-29)

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

Human Growth HormonevsPEG-MGF

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

Human Growth HormonevsSermorelin

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

Human Growth HormonevsTesamorelin

Two fda-approved compounds in growth hormone, compared on the published evidence.

IGF-1 LR3vsIpamorelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

IGF-1 LR3vsMGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

IGF-1 LR3vsMod-GRF (1-29)

Two research / preclinical compounds in growth hormone, compared on the published evidence.

IGF-1 LR3vsPEG-MGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

IGF-1 LR3vsSermorelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

TesamorelinvsIGF-1 LR3

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

IpamorelinvsMGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

IpamorelinvsMod-GRF (1-29)

Two research / preclinical compounds in growth hormone, compared on the published evidence.

IpamorelinvsPEG-MGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

TesamorelinvsIpamorelin

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

MGFvsMod-GRF (1-29)

Two research / preclinical compounds in growth hormone, compared on the published evidence.

MGFvsPEG-MGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

MGFvsSermorelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

TesamorelinvsMGF

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

Mod-GRF (1-29)vsPEG-MGF

Two research / preclinical compounds in growth hormone, compared on the published evidence.

Mod-GRF (1-29)vsSermorelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

TesamorelinvsMod-GRF (1-29)

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

PEG-MGFvsSermorelin

Two research / preclinical compounds in growth hormone, compared on the published evidence.

TesamorelinvsPEG-MGF

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside growth hormone.

Skin & cosmetic.

GHK-CuvsArgireline

Copper peptide vs 'topical Botox': two very different cosmetic mechanisms.

ArgirelinevsMatrixyl

Two of the best-known cosmetic peptides in serums, side by side.

AfamelanotidevsArgireline

FDA-approved vs Cosmetic / topical, a regulatory-reality comparison inside skin & cosmetic.

AfamelanotidevsGHK-Cu

FDA-approved vs Cosmetic / topical, a regulatory-reality comparison inside skin & cosmetic.

AfamelanotidevsMatrixyl

FDA-approved vs Cosmetic / topical, a regulatory-reality comparison inside skin & cosmetic.

AfamelanotidevsMelanotan II

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside skin & cosmetic.

AfamelanotidevsPTD-DBM

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside skin & cosmetic.

AfamelanotidevsSNAP-8

FDA-approved vs Cosmetic / topical, a regulatory-reality comparison inside skin & cosmetic.

Melanotan IIvsArgireline

Research / preclinical vs Cosmetic / topical, a regulatory-reality comparison inside skin & cosmetic.

PTD-DBMvsArgireline

Research / preclinical vs Cosmetic / topical, a regulatory-reality comparison inside skin & cosmetic.

ArgirelinevsSNAP-8

Two cosmetic / topical compounds in skin & cosmetic, compared on the published evidence.

GHK-CuvsMatrixyl

Two cosmetic / topical compounds in skin & cosmetic, compared on the published evidence.

Melanotan IIvsGHK-Cu

Research / preclinical vs Cosmetic / topical, a regulatory-reality comparison inside skin & cosmetic.

PTD-DBMvsGHK-Cu

Research / preclinical vs Cosmetic / topical, a regulatory-reality comparison inside skin & cosmetic.

GHK-CuvsSNAP-8

Two cosmetic / topical compounds in skin & cosmetic, compared on the published evidence.

Melanotan IIvsMatrixyl

Research / preclinical vs Cosmetic / topical, a regulatory-reality comparison inside skin & cosmetic.

PTD-DBMvsMatrixyl

Research / preclinical vs Cosmetic / topical, a regulatory-reality comparison inside skin & cosmetic.

MatrixylvsSNAP-8

Two cosmetic / topical compounds in skin & cosmetic, compared on the published evidence.

Melanotan IIvsPTD-DBM

Two research / preclinical compounds in skin & cosmetic, compared on the published evidence.

Melanotan IIvsSNAP-8

Research / preclinical vs Cosmetic / topical, a regulatory-reality comparison inside skin & cosmetic.

PTD-DBMvsSNAP-8

Research / preclinical vs Cosmetic / topical, a regulatory-reality comparison inside skin & cosmetic.

Longevity.

MOTS-cvs5-Amino-1MQ

Two 'longevity/metabolic' compounds sold together: one a peptide, one not.

EpitalonvsMOTS-c

Two hype-prone longevity peptides, graded on what's actually published.

5-Amino-1MQvsEpitalon

Two research / preclinical compounds in longevity, compared on the published evidence.

5-Amino-1MQvsFOXO4-DRI

Two research / preclinical compounds in longevity, compared on the published evidence.

5-Amino-1MQvsGlutathione

Two research / preclinical compounds in longevity, compared on the published evidence.

5-Amino-1MQvsHumanin

Two research / preclinical compounds in longevity, compared on the published evidence.

SS-31vs5-Amino-1MQ

In human trials vs Research / preclinical, a regulatory-reality comparison inside longevity.

5-Amino-1MQvsVilon

Two research / preclinical compounds in longevity, compared on the published evidence.

EpitalonvsFOXO4-DRI

Two research / preclinical compounds in longevity, compared on the published evidence.

EpitalonvsGlutathione

Two research / preclinical compounds in longevity, compared on the published evidence.

EpitalonvsHumanin

Two research / preclinical compounds in longevity, compared on the published evidence.

SS-31vsEpitalon

In human trials vs Research / preclinical, a regulatory-reality comparison inside longevity.

EpitalonvsVilon

Two research / preclinical compounds in longevity, compared on the published evidence.

FOXO4-DRIvsGlutathione

Two research / preclinical compounds in longevity, compared on the published evidence.

FOXO4-DRIvsHumanin

Two research / preclinical compounds in longevity, compared on the published evidence.

FOXO4-DRIvsMOTS-c

Two research / preclinical compounds in longevity, compared on the published evidence.

SS-31vsFOXO4-DRI

In human trials vs Research / preclinical, a regulatory-reality comparison inside longevity.

FOXO4-DRIvsVilon

Two research / preclinical compounds in longevity, compared on the published evidence.

GlutathionevsHumanin

Two research / preclinical compounds in longevity, compared on the published evidence.

GlutathionevsMOTS-c

Two research / preclinical compounds in longevity, compared on the published evidence.

SS-31vsGlutathione

In human trials vs Research / preclinical, a regulatory-reality comparison inside longevity.

GlutathionevsVilon

Two research / preclinical compounds in longevity, compared on the published evidence.

HumaninvsMOTS-c

Two research / preclinical compounds in longevity, compared on the published evidence.

SS-31vsHumanin

In human trials vs Research / preclinical, a regulatory-reality comparison inside longevity.

HumaninvsVilon

Two research / preclinical compounds in longevity, compared on the published evidence.

SS-31vsMOTS-c

In human trials vs Research / preclinical, a regulatory-reality comparison inside longevity.

MOTS-cvsVilon

Two research / preclinical compounds in longevity, compared on the published evidence.

SS-31vsVilon

In human trials vs Research / preclinical, a regulatory-reality comparison inside longevity.

Cognition & mood.

SemaxvsSelank

The nootropic vs the anxiolytic of the Russian research-peptide pair.

CerebrolysinvsCortexin

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

CerebrolysinvsDihexa

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

CerebrolysinvsDSIP

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

CerebrolysinvsN-Acetyl Semax Amidate

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

CerebrolysinvsP21

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

CerebrolysinvsPE-22-28

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

CerebrolysinvsPinealon

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

CerebrolysinvsSelank

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

CerebrolysinvsSemax

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

CortexinvsDihexa

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

CortexinvsDSIP

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

CortexinvsN-Acetyl Semax Amidate

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

CortexinvsP21

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

CortexinvsPE-22-28

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

CortexinvsPinealon

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

CortexinvsSelank

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

CortexinvsSemax

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

DihexavsDSIP

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

DihexavsN-Acetyl Semax Amidate

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

DihexavsP21

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

DihexavsPE-22-28

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

DihexavsPinealon

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

DihexavsSelank

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

DihexavsSemax

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

DSIPvsN-Acetyl Semax Amidate

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

DSIPvsP21

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

DSIPvsPE-22-28

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

DSIPvsPinealon

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

DSIPvsSelank

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

DSIPvsSemax

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

N-Acetyl Semax AmidatevsP21

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

N-Acetyl Semax AmidatevsPE-22-28

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

N-Acetyl Semax AmidatevsPinealon

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

N-Acetyl Semax AmidatevsSelank

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

N-Acetyl Semax AmidatevsSemax

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

P21vsPE-22-28

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

P21vsPinealon

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

P21vsSelank

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

P21vsSemax

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

PE-22-28vsPinealon

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

PE-22-28vsSelank

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

PE-22-28vsSemax

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

PinealonvsSelank

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

PinealonvsSemax

Two research / preclinical compounds in cognition & mood, compared on the published evidence.

Sexual health.

PT-141vsKisspeptin

Two different routes to libido: melanocortin agonist vs GnRH driver.

GonadorelinvsHCG

Two fda-approved compounds in sexual health, compared on the published evidence.

GonadorelinvsKisspeptin

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside sexual health.

GonadorelinvsOxytocin

Two fda-approved compounds in sexual health, compared on the published evidence.

GonadorelinvsPT-141

Two fda-approved compounds in sexual health, compared on the published evidence.

HCGvsKisspeptin

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside sexual health.

HCGvsOxytocin

Two fda-approved compounds in sexual health, compared on the published evidence.

HCGvsPT-141

Two fda-approved compounds in sexual health, compared on the published evidence.

OxytocinvsKisspeptin

FDA-approved vs Research / preclinical, a regulatory-reality comparison inside sexual health.

OxytocinvsPT-141

Two fda-approved compounds in sexual health, compared on the published evidence.

Immune & inflammation.

KPVvsLL-37

Two research / preclinical compounds in immune & inflammation, compared on the published evidence.

KPVvsThymalin

Two research / preclinical compounds in immune & inflammation, compared on the published evidence.

Thymosin α-1vsKPV

In human trials vs Research / preclinical, a regulatory-reality comparison inside immune & inflammation.

KPVvsVIP

Two research / preclinical compounds in immune & inflammation, compared on the published evidence.

LL-37vsThymalin

Two research / preclinical compounds in immune & inflammation, compared on the published evidence.

Thymosin α-1vsLL-37

In human trials vs Research / preclinical, a regulatory-reality comparison inside immune & inflammation.

LL-37vsVIP

Two research / preclinical compounds in immune & inflammation, compared on the published evidence.

Thymosin α-1vsThymalin

In human trials vs Research / preclinical, a regulatory-reality comparison inside immune & inflammation.

ThymalinvsVIP

Two research / preclinical compounds in immune & inflammation, compared on the published evidence.

Thymosin α-1vsVIP

In human trials vs Research / preclinical, a regulatory-reality comparison inside immune & inflammation.

Compounds